Inherited disorders of platelets. Membrane glycoprotein disorders

Hematology/Oncology Clinics of North America

Volumn 27, Issue 3, 2013, Pages 613-627

  Diz Kücükkaya, Reyhan ^a   López, José A ^b,c,d  

^a FLORENCE NIGHTINGALE HOSPITAL   (Turkey)

^b PUGET SOUND BLOOD CENTER   (United States)

^c UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Bernard Soulier syndrome; Glanzmann thrombasthenia; Inherited bleeding tendency; Platelet disorders; Platelet glycoproteins

Indexed keywords

ALPHA2 INTEGRIN; COLLAGEN RECEPTOR; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; GLYCOPROTEIN IB ALPHA;

ARTERY THROMBOSIS; BERNARD SOULIER DISEASE; DISEASE SEVERITY; DNA POLYMORPHISM; EPISTAXIS; GENE MUTATION; GENETIC DISORDER; GINGIVA BLEEDING; GLANZMANN DISEASE; HEMOSTASIS; HUMAN; MENORRHAGIA; NONHUMAN; PATIENT CARE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PURPURA; REVIEW; THROMBOCYTE DISORDER; THROMBOCYTOPENIA; VARIABLE NUMBER OF TANDEM REPEAT; VELOCARDIOFACIAL SYNDROME; VON WILLEBRAND DISEASE;

BLOOD PLATELET DISORDERS; HUMANS; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PLATELET MEMBRANE GLYCOPROTEINS; RECEPTORS, COLLAGEN;

EID: 84878260068     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2013.03.005     Document Type: Review

References (80)

1. Modderman P.W., Admiraal L.G., Sonnenberg A., et al. Glycoproteins V and Ib-IX form a noncovalent complex in the platelet membrane. J Biol Chem 1992, 267:364-369.
2. Luo S.Z., Mo X., Afshar-Kharghan V., et al. Glycoprotein Ibα forms disulfide bonds with 2 glycoprotein Ibβ subunits in the resting platelet. Blood 2007, 109(2):603-609.
3. Botos I., Segal D.M., Davies D.R. The structural biology of Toll-like receptors. Structure 2011, 19(4):447-459.
4. Du X. Signaling and regulation of the platelet glycoprotein Ib-IX-V complex. Curr Opin Hematol 2007, 14(3):262-269.
5. Dong J.F., Gao S., López J.A. Synthesis, assembly, and intracellular transport of the platelet glycoprotein Ib-IX-V complex. J Biol Chem 1998, 273(47):31449-31454.
6. Schick P.K., Walker J. The acylation of megakaryocyte proteins: glycoprotein IX is primarily myristoylated while glycoprotein Ib is palmitoylated. Blood 1996, 87(4):1377-1384.
7. Dong J.F., Li C.Q., López J.A. Tyrosine sulfation of the GP Ib-IX complex: identification of sulfated residues and effect on ligand binding. Biochemistry 1994, 33:13946-13953.
8. Ward C.M., Andrews R.K., Smith A.I., et al. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibα. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibα as a binding site for von Willebrand factor and α-thrombin. Biochemistry 1996, 35:4929-4938.
9. López J.A., Andrews R.K., Afshar-Kharghan V., et al. Bernard-Soulier syndrome. Blood 1998, 91(12):4397-4418.
10. Lanza F. Bernard-Soulier syndrome (hemorrhagiparous thrombocytic dystrophy). Orphanet J Rare Dis 2006, 1:46.
11. López J.A. The platelet glycoprotein Ib-IX complex. Blood Coagul Fibrinolysis 1994, 5:97-119.
12. Harmon J.T., Jamieson G.A. The glycocalicin portion of platelet glycoprotein Ib expresses both high and moderate affinity receptor sites for thrombin. A soluble radioreceptor assay for the interaction of thrombin with platelets. J Biol Chem 1986, 261:13224-13229.
13. Romo G.M., Dong J.F., Schade A.J., et al. The glycoprotein Ib-IX-V complex is a platelet counter-receptor for P-selectin. J Exp Med 1999, 190:803-813.
14. Simon D.I., Chen Z., Xu H., et al. Platelet glycoprotein Ibα is a counterreceptor for the leukocyte integrin Mac-1 (CD11b/CD18). J Exp Med 2000, 192(2):193-204.
15. Baglia F.A., Badellino K.O., Li C.Q., et al. Factor XI binding to the platelet glycoprotein Ib-IX-V complex promotes factor XI activation by thrombin. J Biol Chem 2002, 277(3):1662-1668.
16. Bradford H.N., Pixley R.A., Colman R.W. Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation. J Biol Chem 2000, 275(30):22756-22763.
17. Joseph K., Nakazawa Y., Bahou W.F., et al. Platelet glycoprotein Ib: a zinc-dependent binding protein for the heavy chain of high-molecular-weight kininogen. Mol Med 1999, 5(8):555-563.
18. Jurk K., Clemetson K.J., de Groot P.G., et al. Thrombospondin-1 mediates platelet adhesion at high shear via glycoprotein Ib (GPIb): an alternative/backup mechanism to von Willebrand factor. FASEB J 2003, 17(11):1490-1492.
19. Hulstein J.J., Lenting P.J., de L.B., et al. β2-Glycoprotein I inhibits von Willebrand factor dependent platelet adhesion and aggregation. Blood 2007, 110(5):1483-1491.
20. Moake J.L., Rudy C.K., Troll J.H., et al. Unusually large plasma factor VIII:von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 1982, 307(23):1432-1435.
21. Dong J.F., Moake J.L., Nolasco L., et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002, 100(12):4033-4039.
22. Brill A., Fuchs T.A., Chauhan A.K., et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood 2011, 117(4):1400-1407.
23. Katayama T., Ikeda Y., Handa M., et al. Immunoneutralization of glycoprotein Ibα attenuates endotoxin-induced interactions of platelets and leukocytes with rat venular endothelium in vivo. Circ Res 2000, 86(10):1031-1037.
24. Ehlers R., Ustinov V., Chen Z., et al. Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibα. J Exp Med 2003, 198(7):1077-1088.
25. Wang Y., Sakuma M., Chen Z., et al. Leukocyte engagement of platelet glycoprotein Ibα via the integrin Mac-1 is critical for the biological response to vascular injury. Circulation 2005, 112(19):2993-3000.
26. Heyns A.D., Badenhorst P.N., Wessels P., et al. Kinetics, in vivo redistribution and sites of sequestration of indium-111-labelled platelets in giant platelet syndromes. Br J Haematol 1985, 60(2):323-330.
27. Strassel C., Eckly A., Leon C., et al. Intrinsic impaired proplatelet formation and microtubule coil assembly of megakaryocytes in a mouse model of Bernard-Soulier syndrome. Haematologica 2009, 94(6):800-810.
28. Balduini A., Malara A., Pecci A., et al. Proplatelet formation in heterozygous Bernard-Soulier syndrome type Bolzano. J Thromb Haemost 2009, 7(3):478-484.
29. Poujol C., Ware J., Nieswandt B., et al. Absence of GPIbα is responsible for aberrant membrane development during megakaryocyte maturation: ultrastructural study using a transgenic model. Exp Hematol 2002, 30(4):352-360.
30. Harrison P., Robinson M., Liesner R., et al. The PFA-100: a potential rapid screening tool for the assessment of platelet dysfunction. Clin Lab Haematol 2002, 24(4):225-232.
31. Coller B.S., Peerschke E.I., Lesley E., et al. Studies with a murine monoclonal antibody that abolishes ristocetin-induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor. Blood 1983, 61(1):99-110.
32. Miller J.L., Lyle V.A., Cunningham D. Mutation of leucine-57 to phenylalanine in a platelet glycoprotein Ibα leucine tandem repeat occurring in patients with an autosomal dominant variant of Bernard-Soulier disease. Blood 1992, 79:439-446.
33. Girolami A., Vettore S., Vianello F., et al. Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard-Soulier syndrome. J Thromb Thrombolysis 2012, 34(4):513-517.
34. Savoia A., Balduini C.L., Savino M., et al. Autosomal dominant macrothrombocytopenia in Italy is most frequently a type of heterozygous Bernard-Soulier syndrome. Blood 2001, 97(5):1330-1335.
35. Noris P., Perrotta S., Bottega R., et al. Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbalpha (Bolzano mutation). Haematologica 2012, 97(1):82-88.
36. Li C.Q., Dong J.F., Lanza F., et al. Expression of platelet glycoprotein (GP) V in heterologous cells and evidence for its association with GP Ibα in forming a GP Ib-IX-V complex on the cell surface. J Biol Chem 1995, 270(27):16302-16307.
37. Othman M., López J.A., Ware J. Platelet-type von Willebrand disease update: the disease, the molecule and the animal model. Expert Rev Hematol 2011, 4(5):475-477.
38. Enayat S., Ravanbod S., Rassoulzadegan M., et al. A novel D235Y mutation in the GP1BA gene enhances platelet interaction with von Willebrand factor in an Iranian family with platelet-type von Willebrand disease. Thromb Haemost 2012, 108(5):946-954.
39. Favaloro E.J., Patterson D., Denholm A., et al. Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis. Br J Haematol 2007, 139(4):623-626.
40. Giannini S., Cecchetti L., Mezzasoma A.M., et al. Diagnosis of platelet-type von Willebrand disease by flow cytometry. Haematologica 2010, 95(6):1021-1024.
41. Liang H.P., Morel-Kopp M.C., Curtin J., et al. Heterozygous loss of platelet glycoprotein (GP) Ib-V-IX variably affects platelet function in velocardiofacial syndrome (VCFS) patients. Thromb Haemost 2007, 98(6):1298-1308.
42. López J.A., Ludwig E.H., McCarthy B.J. Polymorphism of human glycoprotein Ibα results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 1992, 267:10055-10061.
43. Li C.Q., Dong J.F., López J.A. The mucin-like macroglycopeptide region of glycoprotein Ibα is required for cell adhesion to immobilized von Willebrand factor (VWF) under flow but not for static VWF binding. Thromb Haemost 2002, 88(4):673-677.
44. Gonzalez-Conejero R., Lozano M.L., Rivera J., et al. Polymorphisms of platelet membrane glycoprotein Ibα associated with arterial thrombotic disease. Blood 1998, 92(8):2771-2776.
45. Afshar-Kharghan V., Matijevic-Aleksic N., Ahn C., et al. The variable number of tandem repeat polymorphism of platelet glycoprotein Ibalpha and risk of coronary heart disease. Blood 2004, 103(3):963-965.
46. Murata M., Furihata K., Ishida F., et al. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ibα involved in platelet transfusion refractoriness. Blood 1992, 79:3086-3090.
47. Simsek S., Bleeker P.M., van der Schoot C.E., et al. Association of variable number of tandem repeats (VNTR) in glycoprotein Ibα and HPA-2 alloantigens. Thromb Haemost 1994, 72(5):757-761.
48. Afshar-Kharghan V., Li C.Q., Khoshnevis-Asl M., et al. Kozak sequence polymorphism of the glycoprotein (GP) Ibα gene is a major determinant of the plasma membrane levels of the platelet GP Ib- IX-V complex. Blood 1999, 94(1):186-191.
49. Baker R.I., Eikelboom J., Lofthouse E., et al. Platelet glycoprotein Ibα Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 2001, 98(1):36-40.
50. Meisel C., Afshar-Kharghan V., Cascorbi I., et al. Role of Kozak sequence polymorphism of platelet glycoprotein Ibα as a risk factor for coronary artery disease and catheter interventions. J Am Coll Cardiol 2001, 38(4):1023-1027.
51. Maguire J.M., Thakkinstian A., Sturm J., et al. Polymorphisms in platelet glycoprotein 1bα and factor VII and risk of ischemic stroke: a meta-analysis. Stroke 2008, 39(6):1710-1716.
52. Chevalier J., Nurden A.T., Thiery J.M., et al. Freeze-fracture studies on the plasma membranes of normal human, thrombasthenic, and Bernard-Soulier platelets. J Lab Clin Med 1979, 94:232-245.
53. Bray P.F., Howard T.D., Vittinghoff E., et al. Effect of genetic variations in platelet glycoproteins Ibα and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy. Blood 2007, 109(5):1862-1869.
54. Yonal I., Hindilerden F., Hancer V.S., et al. The impact of platelet membrane glycoprotein Ibα and Ia/IIa polymorphisms on the risk of thrombosis in the antiphospholipid syndrome. Thromb Res 2012, 129(4):486-491.
55. Phillips D.R., Charo I.F., Parise L.V., et al. The platelet membrane glycoprotein IIb-IIIa complex. Blood 1988, 71:831-843.
56. Wagner C.L., Mascelli M.A., Neblock D.S., et al. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets. Blood 1996, 88(3):907-914.
57. Bennett J.S., Berger B.W., Billings P.C. The structure and function of platelet integrins. J Thromb Haemost 2009, 7(SUPPL 1):200-205.
58. Shattil S.J., Newman P.J. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 2004, 104(6):1606-1615.
59. Armstrong P.C., Peter K. GPIIb/IIIa inhibitors: from bench to bedside and back to bench again. Thromb Haemost 2012, 107(5):808-814.
60. George J.N., Caen J.P., Nurden A.T. Glanzmann's thrombasthenia: the spectrum of clinical disease. Blood 1990, 75(7):1383-1395.
61. Nurden A.T. Glanzmann thrombasthenia. Orphanet J Rare Dis 2006, 1:10.
62. Salles I.I., Feys H.B., Iserbyt B.F., et al. Inherited traits affecting platelet function. Blood Rev 2008, 22(3):155-172.
63. McHugh K.P., Hodivala-Dilke K., Zheng M.H., et al. Mice lacking β3 integrins are osteosclerotic because of dysfunctional osteoclasts. J Clin Invest 2000, 105(4):433-440.
64. Reynolds A.R., Reynolds L.E., Nagel T.E., et al. Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in β3-integrin-deficient mice. Cancer Res 2004, 64(23):8643-8650.
65. Metcalfe P. Platelet antigens and antibody detection. Vox Sang 2004, 87(SUPPL 1):82-86.
66. Weiss E.J., Bray P.F., Tayback M., et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996, 334(17):1090-1094.
67. Vijayan K.V., Liu Y., Sun W., et al. The Pro33 isoform of integrin β3 enhances outside-in signaling in human platelets by regulating the activation of serine/threonine phosphatases. J Biol Chem 2005, 280(23):21756-21762.
68. Kucharska-Newton A.M., Monda K.L., Campbell S., et al. Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 2011, 216(1):151-156.
69. Zhu M.M., Weedon J., Clark L.T. Meta-analysis of the association of platelet glycoprotein IIIa PlA1/A2 polymorphism with myocardial infarction. Am J Cardiol 2000, 86(9):1000-1005. A8.
70. Nieswandt B., Schulte V., Bergmeier W., et al. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J Exp Med 2001, 193(4):459-469.
71. Arthur J.F., Dunkley S., Andrews R.K. Platelet glycoprotein VI-related clinical defects. Br J Haematol 2007, 139(3):363-372.
72. Kato K., Kanaji T., Russell S., et al. The contribution of glycoprotein VI to stable platelet adhesion and thrombus formation illustrated by targeted gene deletion. Blood 2003, 102(5):1701-1707.
73. Shaffer J.R., Kammerer C.M., Dorn J., et al. Polymorphisms in the platelet-specific collagen receptor GP6 are associated with risk of nonfatal myocardial infarction in Caucasians. Nutr Metab Cardiovasc Dis 2011, 21(8):546-552.
74. Handa M., Watanabe K., Kawai Y., et al. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (α2β1 integrin) deficiency associated with a myeloproliferative disorder. Thromb Haemost 1995, 73(3):521-528.
75. Tosetto A., Castaman G., Rodeghiero F. Bleeding scores in inherited bleeding disorders: clinical or research tools?. Haemophilia 2008, 14(3):415-422.
76. Bolton-Maggs P.H., Chalmers E.A., Collins P.W., et al. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006, 135(5):603-633.
77. Nurden A.T., Freson K., Seligsohn U. Inherited platelet disorders. Haemophilia 2012, 18(SUPPL 4):154-160.
78. Drachman J.G. Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood 2004, 103(2):390-398.
79. Balduini C.L., Cattaneo M., Fabris F., et al. Inherited thrombocytopenias: a proposed diagnostic algorithm from the Italian Gruppo di Studio delle Piastrine. Haematologica 2003, 88(5):582-592.
80. Seligsohn U. Treatment of inherited platelet disorders. Haemophilia 2012, 18(SUPPL 4):161-165.